Mohamed Abdelalim

About

De novo Drug Discovery

I'm a PULSe PhD student, formerly a Visiting Research Investigator, focused on building fully automated pipelines for de novo drug discovery — combining machine learning, cheminformatics, and structure-based design to generate and predict novel kinase inhibitors.

Trained as a pharmacist, I bridge medicinal chemistry with AI, and work as a software developer building applications for science communication. Outside the lab, graphic design and animation are a long-standing hobby of mine, from visual identities to health awareness campaigns.